How is high-risk multiple myeloma determined?

#HTUmyeloma

High-risk multiple myeloma (HRMM) is a subtype of multiple myeloma characterized by faster disease progression, less favorable response to standard treatments, and a shorter overall survival compared to standard-risk myeloma. It's identified by specific genetic alterations, clinical features, and treatment outcomes.

This Healthtree University lesson will review the criteria that is evaluated to make this classification.

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_so...

Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.